Article Abstract

Lung cancer screening: tell me more about post-test risk

Authors: Mario Silva, Gianluca Milanese, Ugo Pastorino, Nicola Sverzellati

Abstract

Lung cancer screening (LCS) by low-dose computed tomography (LDCT) can save lives because LC is detected in its early asymptomatic stage (1). We have come a long way since the first results of the national lung screening trial (NLST) (2), now confirmed in Europe by volumetric LDCT against control arm by the Nederlands Leuvens Longkanker Screenings Onderzoek (NELSON) (3) and the multicentric Italian lung detection (MILD) (4).